22 June 2021 - 08:00-12:00

1: MUNIX -  a progression marker of motor neuron loss.
Markus Weber, St. Gallen, Switzerland

2: Phrenic nerve conduction studies in ALS
Mamede de Carvalho, Lisbon, Portugal

Christoph Neuwirth, St. Gallen, Switzerland

Sanjeev Nandedkar, New York, United States of America

1: Covert Brain Infarction: Towards Precision Medicine in Research, Diagnosis, and Therapy for a Silent Pandemic
Thomas Meinel, Bern, Switzerland

2: The importance of hypertension in secondary stroke prevention
Linxin Li, Oxford, United Kingdom

3: Acute stroke management: drip-and-ship or mothership?
Marc Ribó, Barcelona, Spain

4: Secondary stroke prevention for cardioembolic stroke: PFO, LAAO, Atrial cardiopathy, cardiac imaging (CT/ MRI) for detection of cardiac source of embolism.
Mira Katan, Zurich, Switzerland

1: Imaging methods to predict and monitor individual disease courses
Christian Enzinger, Graz, Austria

2: Bodyfluid-biomarkers in multiple sclerosis and related disorders: diagnose, predict, monitor
Charlotte Teunissen, Amsterdam, The Netherlands

3: Virtual monitoring of MS patients by digital biomarkers– lessons learned from the COVID19-pandemia
Yvonne Naegelin, Basel, Switzerland

4: Disease-modifying treatments in MS – how to individualize treatment decisions in daily routine practice?
Mar Tintore, Barcelona, Spain

1: Strengths & limitations of statistical analyses
Derrick Bennett, Oxford, United Kingdom

2: Statistics in observational studies
Josemir Sander, London, United Kingdom

3: Statistics in randomized clinical trials
Ettore Beghi, Milano, Italy

4: Statistics in meta-analyses
Johannes Vester, Krailling, Germany

1: A case of vertical supranuclear gaze palsy
Kailash Bhatia, London, United Kingdom

2: A case with slow saccades
Wolfgang Nachbauer, Innsbruck, Austria

3: Progressive ophthalmoparesis with eyelid ptosis
Michelangelo Mancuso, Pisa, Italy

1: Early onset generalized dystonia – the new one (KMT2B) 
Michael Zech, Munich, Germany

2 Dystonias of the young and the adult (DYT1, GNAL, THAP, MD, ANO3) 
Sylvia Boesch, Innsbruck, Austria

3: ATP1A3 spectrum disease
Emmanuel Flamand-Roze, Paris, France

TBA

1: World Federation of Neurology Expanding Role in Education
William Carroll, Perth, Australia

2: WFN Existing Educational Activities
Steven Lewis, Pennsylvania, United States of America

3: New Activities. The WFN Needs Registry.
Wolfgang Grisold, Vienna, Austria

4: WFN
Marianne de Visser, Amsterdam, The Netherlands

5: Q & A
All faculty

TBA